Elon Musk Shares Bold Vision for AI, Robots, and Space at Davos 
Sanofi Reports Positive Late-Stage Results for Amlitelimab in Eczema Treatment 
Hermès Menswear Marks Historic Transition as Véronique Nichanian Bids Farewell in Paris 
NTSB Opens Investigation Into Waymo Robotaxis After School Bus Safety Violations in Texas 
Trump Lawsuit Against JPMorgan Signals Rising Tensions Between Wall Street and the White House 
SEC Drops Gemini Enforcement Case After Full Repayment to Earn Investors 
Goldman Sachs CEO David Solomon’s 2025 Pay Soars to $47 Million After Strong Deal-Making Year 
Delta Air Lines Operates Reduced Flight Schedule as Winter Storm Disrupts U.S. Travel 
ByteDance Finalizes Majority U.S.-Owned TikTok Joint Venture to Avert American Ban 
Ryanair Profit Slumps in Q3 After Italy Antitrust Fine Despite Revenue Growth 
LVMH Succession Uncertainty Raises Governance Concerns Among Shareholders 
FCC Chairman Raises Competition Concerns Over Netflix–Warner Bros. Discovery Deal 
Trump Administration Takes Stake in USA Rare Earth to Boost U.S. Critical Minerals Supply 
Tesla Plans FSD Subscription Price Hikes as Autonomous Capabilities Advance 
Winter Storm Triggers Widespread Flight Cancellations Across U.S. as Airlines Urge Travelers to Rebook 
BURLINGTON, Mass., May 11, 2017 -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will be participating in three investor conferences.
George LeMaitre, Chairman & CEO, is scheduled to present at the East Coast IDEAS Investor Conference in Boston on Wednesday, May 17, 2017 at the Boston Park Plaza. The Company’s presentation is scheduled to begin at 10:00 AM EDT.
JJ Pellegrino, Chief Financial Officer, will participate in the Benchmark Company, LLC One-on-One Investor Conference on Thursday, June 1, 2017 at the Palmer House Hilton in Chicago, IL.
JJ Pellegrino, Chief Financial Officer, is scheduled to present at the Jefferies 2017 Global Healthcare Conference on Tuesday, June 6, 2017 at the Grand Hyatt in New York, NY. The Company’s presentation is scheduled to begin at 3:30 PM EDT.
About LeMaitre Vascular
LeMaitre Vascular is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. The Company's diversified product portfolio consists of brand name devices used in arteries and veins outside of the heart. Additional information can be found at www.lemaitre.com.
Contact: LeMaitre Vascular, Inc. Investor Relations Steven Chehames +1-781-425-1659 [email protected]
